Dakota Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
2,506
-119
-5% -$54.9K 0.03% 384
2026
Q1
$1.26M Buy
2,625
+971
+59% +$497K 0.03% 362
2025
Q4
$929K Buy
1,654
+541
+49% +$307K 0.02% 421
2025
Q3
$572K Sell
1,113
-743
-40% -$324K 0.01% 455
2025
Q2
$583K Sell
1,856
-259
-12% -$77.8K 0.01% 495
2025
Q1
$644K Buy
2,115
+1,383
+189% +$465K 0.02% 464
2024
Q4
$243K Sell
732
-522
-42% -$177K 0.01% 671
2024
Q3
$418K Sell
1,254
-9,154
-88% -$3.48M 0.01% 532
2024
Q2
$4.29M Buy
10,408
+3,161
+44% +$1.25M 0.1% 173
2024
Q1
$2.93M Buy
7,247
+97
+1% +$34.1K 0.07% 219
2023
Q4
$2.19M Buy
7,150
+4,251
+147% +$1.15M 0.09% 213
2023
Q3
$702K Buy
2,899
+8
+0.3% +$2.05K 0.03% 339
2023
Q2
$694K Sell
2,891
-142
-5% -$29.5K 0.03% 319
2023
Q1
$570K Buy
3,033
+1,243
+69% +$257K 0.04% 340
2022
Q4
$380K Buy
+1,790
New +$358K 0.03% 405

Other funds holding MEDP

Dakota Wealth Management's MEDP Position: Q2 2026 in Review

Dakota Wealth Management reduced its Medpace (MEDP) stake by 4.5% in Q2 2026, selling an estimated $54.9K and leaving 2,506 shares worth $1.33M. The position accounts for 0.03% of the portfolio, ranked #384.

Dakota Wealth Management first reported a position in MEDP in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.29M in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Dakota Wealth Management held 2,506 shares of Medpace worth $1.33M as of Q2 2026.
  • Dakota Wealth Management sold 119 Medpace shares in Q2 2026, an estimated $54.9K.
  • Medpace made up 0.03% of Dakota Wealth Management's portfolio in Q2 2026, its #384 holding.
  • Dakota Wealth Management first reported a position in Medpace in Q4 2022 and has held it in 15 quarters since.
  • Dakota Wealth Management's Medpace position peaked at $4.29M in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.